StockNews.com initiated coverage on shares of Mannatech (NASDAQ:MTEX – Free Report) in a research note published on Thursday morning. The brokerage issued a buy rating on the stock.
Mannatech Price Performance
MTEX stock opened at $6.95 on Thursday. The company has a 50 day moving average price of $7.74 and a two-hundred day moving average price of $8.34. The company has a quick ratio of 0.56, a current ratio of 1.08 and a debt-to-equity ratio of 0.09. Mannatech has a one year low of $6.75 and a one year high of $15.10.
Mannatech (NASDAQ:MTEX – Get Free Report) last announced its quarterly earnings data on Tuesday, May 14th. The company reported $0.63 EPS for the quarter. Mannatech had a negative return on equity of 15.37% and a negative net margin of 1.31%. The business had revenue of $29.39 million during the quarter.
About Mannatech
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
Featured Stories
- Five stocks we like better than Mannatech
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- BlackBerry Stock: Strong Earnings, Profitability Challenges Ahead
- Investing In Preferred Stock vs. Common Stock
- Progress Software Stock Back in the Green After Beating Forecasts
- Most active stocks: Dollar volume vs share volume
- Goldman Sachs Raises Stock Target for Affirm: Key Insights
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
